Childrens Hospital and Clinics of Minnesota

Minneapolis, Minnesota 55406

6 studies enrolling now · 22 studies all time

What they study most

ALL, ALL, Childhood, AML, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Undifferentiated Leukemia, Atypical Teratoid Rhabdoid Tumor, BPDCN, Brain Tumors, Cardiac Arrest, Congenital Heart Disease in Children, Cronic Lung Disease

Studies at this site

• Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma — Recruiting now
• Pediatric Precision Laboratory Advanced Neuroblastoma Therapy — Recruiting now
• Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma — Recruiting now
• Beat Childhood Cancer Specimen Banking and Data Registry — Recruiting now
• National Collaborative to Improve Care of Children With Complex Congenital Heart Disease — Recruiting now
• Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies — Recruiting now
• Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma — Running, not enrolling
• Total Therapy for Infants With Acute Lymphoblastic Leukemia (ALL) I — Running, not enrolling
• Neuroblastoma Maintenance Therapy Trial — Running, not enrolling
• Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors — Running, not enrolling
• STeroids to REduce Systemic Inflammation After Infant Heart Surgery — Completed
• A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma — Running, not enrolling
• Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children — Completed
• PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma — Running, not enrolling
• Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia — Completed
• PEACE: Pediatric Antifungal Comparative Effectiveness — Completed
• Alphanate in Immune Tolerance Induction Therapy — Stopped early
• Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignant Brain Tumors — Completed
• A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy — Completed
• Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial — Completed
• Novel Influenza A (H1N1) Surveillance Registry — Completed
• Humidified High Flow Nasal Cannula as Compared to Nasal Continuous Positive Airway Pressure — Completed